ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,576.40
-0.68%
US Tech 100
18,973.20
0.34%
Dow Jones
41,442.33
-1.12%
Brent Oil
69.835
1.15%
Bitcoin
81,262.95
3.55%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Merck & Co Inc (1MRKX) Quote

Merck & Co Inc

Merck & Co Inc (1MRKX)

BIT
87.10
-1.70
( -1.91% )
Updated: 11:49:25
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
87.10
Bid
86.50
Ask
87.30
Volume
80
87.10 Day's Range 87.10
72.00 52 Week Range 124.80
Market Cap
220.018B
Previous Close
88.80
Open
87.10
Last Trade
80
@
87.1
Last Trade Time
07:40:50
Financial Volume
-
VWAP
-
Average Volume (3m)
294
Shares Outstanding
2,526,036,240
Dividend Yield
4.06%
PE Ratio
13.99
Earnings Per Share (EPS)
6.78
Revenue
64.17B
Net Profit
17.12B

About Merck & Co Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.merck.com
Headquarters
West Trenton, New Jersey, USA
Founded
-
Merck & Co Inc is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker 1MRKX. The last closing price for Merck & was 88.80 €. Over the last year, Merck & shares have traded in a share price range of 72.00 € to 124.80 €.

Merck & currently has 2,526,036,240 shares outstanding. The market capitalization of Merck & is 224.31 € billion. Merck & has a price to earnings ratio (PE ratio) of 13.99.

Ask ADVFN Intelligence (AI)

1MRKX Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.7-1.9144144144188.890.58521887.88668197DE
43.13.690476190488490.57235785.0874097DE
12-8.2-8.6044071353695.399.47229488.05279879DE
26-18.1-17.2053231939105.2105.47218390.28493151DE
52-25.9-22.9203539823113124.87212894.05418531DE
156-7.3-7.7330508474694.4124.87212295.93491529DE
260-7.3-7.7330508474694.4124.87212295.93491529DE

1MRKX - Frequently Asked Questions (FAQ)

What is the current Merck & share price?
The current share price of Merck & is 87.10 €
How many Merck & shares are in issue?
Merck & has 2,526,036,240 shares in issue
What is the market cap of Merck &?
The market capitalisation of Merck & is EUR 224.31B
What is the 1 year trading range for Merck & share price?
Merck & has traded in the range of 72.00 € to 124.80 € during the past year
What is the PE ratio of Merck &?
The price to earnings ratio of Merck & is 13.99
What is the cash to sales ratio of Merck &?
The cash to sales ratio of Merck & is 3.73
What is the reporting currency for Merck &?
Merck & reports financial results in USD
What is the latest annual turnover for Merck &?
The latest annual turnover of Merck & is USD 64.17B
What is the latest annual profit for Merck &?
The latest annual profit of Merck & is USD 17.12B
What is the registered address of Merck &?
The registered address for Merck & is 820 BEAR TAVERN ROAD, WEST TRENTON, NEW JERSEY, 08628 1021
What is the Merck & website address?
The website address for Merck & is www.merck.com
Which industry sector does Merck & operate in?
Merck & operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EPHEPH SpA
0.102 €
(30.77%)
596.05k
1NLOKGen Digital Inc
25.00 €
(28.87%)
78
MPTImpianti SpA
0.975 €
(21.88%)
285k
1IDRIndra Sistemas
28.66 €
(14.92%)
800
NTWNetweek SpA
0.0324 €
(10.20%)
482.32k
WFAE25Fae Technology
0.25 €
(-19.35%)
1.34k
1ESSIEssity AB
23.54 €
(-14.09%)
200
1HEN3Henkel AG & Co KGAA
77.50 €
(-11.43%)
46
1HENHenkel AG & Co KGAA
69.75 €
(-10.58%)
667
1MRNAModerna Inc
30.625 €
(-10.48%)
17.01k
TITTelecom Italia SpA
0.2714 €
(-1.24%)
175.98M
ISPIntesa Sanpaolo Spa
4.713 €
(-1.61%)
54.91M
SPMSaipem Spa
1.9765 €
(-0.08%)
30.42M
ENELEnel Spa
6.977 €
(0.53%)
19.76M
TITRTelecom Italia
0.3074 €
(-0.84%)
18.31M

Discussion

View Full Feed
jay_tee jay_tee 39 seconds ago
Pump IT UP!! https://youtu.be/9EcjWd-O4jI?si=q0UEfxDHsm80scet/url] insert-text-here
RNVA
Rainer Rainer 47 seconds ago
off topic, the Trump truth social posts bashing Canada this morning are pretty nuts. Gotta be confusing for the Canadian Trumpers.
Imindog Imindog 1 minute ago
Kenny don’t talk business to these ignorant nimrods it’s like beating your head against the wall wondering how can this many people be really this retarded honestly!! None of these guys know a damn thing about business or numbers or clearly they would know this is trailer trash
IQST
DiscoverGold DiscoverGold 1 minute ago
S&P 500: While government shutdowns can create short-term volatility, historical data shows that the S&P 500 has gained an average of 12.7% in the 12 months after such events, with positive returns occurring 86.4% of the time
By: Isabelnet | March 11, 2025

• S&P 500
NeoSunTzu NeoSunTzu 2 minutes ago
Why did I get a sudden urge to eat a 😽 ... I'm not even Chinese 🥴🤣
BlazingStocks BlazingStocks 2 minutes ago
$COEP - Coeptis had previously held limited co-development rights to GEAR. As part of this exclusive GEAR license agreement with VyGen-Bio, Inc., Coeptis has formed a new majority-owned subsidiary, GEAR Therapeutics, Inc., with the mission to advance GEAR-based cell therapy towards human proof-of-co
COEP
manibiotech manibiotech 2 minutes ago
Answer to your looong post is , After more than a decade "show us the money "
NWBO
biotechinvestor1 biotechinvestor1 3 minutes ago
There used to be another permabear who went by the name easycomeandgo. His predictions and calls were so cconsistently bad, that nearly everytime he made one, it was a sure sign to take the opposite side. I miss him. He helped me buy the dips with surprising accuracy. 
HALO
al44 al44 3 minutes ago
Go gettem-



https://media.gettr.com/group4/getter/2025/03/11/11/7e8d1772-7f04-7aca-f63b-f36069542e6b/8115c24ee5d8aa8bb200a62f0ba26be2_768x0.jpg
TheHappyVulcan TheHappyVulcan 3 minutes ago
This company has a very reasonable value of 51 for an RSI, for the past three months accumulation is on the rise, float remains reasonable, debt load is minimal, no insider sales to speak of and they're in a favored tier for an OTC company.PPS has been rising steadily over the past month or so, too
MEDIF
ace65 ace65 3 minutes ago
Excellent i am holding ..been here awhile and GTSM has been trying to
keep it down forever it seems..i do believe we have a massive short.
VAYK
Ragnar Ragnar 4 minutes ago
Next leg up appears to be starting today.

$RITE
RITE
BCNstocks BCNstocks 4 minutes ago
Nice update out. Additionally, ADIA Nutrition’s CEO, Larry Powalisz, has promoted his longtime intern to aide, offloading key projects, marketing, and social media. This change allows leadership to focus on strategic expansion while maintaining our mission-driven approach.
ADIA
rainmaker71 rainmaker71 4 minutes ago
HUMMINGBIRD....THIS WEEK WOULD BE AN AMAZING TIME TO DROP SOME GOOD NEWS! PLEASE LET THE DOC KNOW
VDRM
DiscoverGold DiscoverGold 4 minutes ago
Silver $SLV - Bullish Tri-Candle Plot Update...
By: Sahara | March 11, 2025

• $SILVER $SLV - Bullish Tri-Candle Plot Update

Held over the Daily 12 & 20/MA's after B/Testing. Hope is here that W-3 of -iii (Blue) is under way....

pbs.twimg.com/
SILVER SLV
SkyLimit2022 SkyLimit2022 5 minutes ago
mani,

Thanks for reposting your insightful advisory. Sounds like you really hit the nail on the head 🔨

https://investorshub.advfn.com/uimage/uploads/2025/3/11/iwfamgiphy.gif

I believe that having a comprehensive IP patent portfolio, commercial li
NWBO
djjazzyjeff djjazzyjeff 5 minutes ago
They said in the shareholders letter they were going to start recruiting people for a phase 2 study in January. It is almost halfway through March and not a word. NOT GOOD
CYDY
againstallodds againstallodds 6 minutes ago
Phony Picasso painting PDIV AGAIN TODAY

MANIPULATION
PDIV
Ezzra Ezzra 6 minutes ago
Feels overdue for some news eh?
CETI
TrendTrade2016 TrendTrade2016 6 minutes ago
PCLA BOTTOM PLAY OFF 66C
PCLA
gfp927z gfp927z 6 minutes ago
Fwiw, I went to 5% with the stock allocation. Still not a large amount, but couldn't resist with the RSI under 30. Trump isn't showing any signs of backing down on the tariffs, but the market seems due for a bounce, albeit a temporary one.



https://m.media-amazon.com
Penny Stocks 2.0 Penny Stocks 2.0 7 minutes ago
Can't wait to steam roll .002, foolishness. Those shares will ne worth 5x minimum  soon..
VAYK

Your Recent History

BIT
1MRKX
Merck &
NASDAQ
ICUI
ICU Medical
NASDAQ
CDMJX
Ci Global Dividend Oppor...
TG
A2R3SR
Republic of Croatia
BOV
N2ET34Q
Cloudflare
AMEX
IYG
iShares US Financial Ser...
DOWI
DJCIGRP
DJ Commodity Index Grain...
NYSE
CM
Canadian Imperial Bank o...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads